Ardent Health Partners (NYSE:ARDT) Price Target Raised to $25.00

Ardent Health Partners (NYSE:ARDT - Get Free Report) had its price target raised by stock analysts at Leerink Partners from $23.00 to $25.00 in a note issued to investors on Tuesday,Benzinga reports. The firm currently has an "outperform" rating on the stock. Leerink Partners' price objective would suggest a potential upside of 45.60% from the stock's current price.

ARDT has been the subject of several other reports. JPMorgan Chase & Co. assumed coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They set a "neutral" rating and a $18.00 target price for the company. Citigroup started coverage on shares of Ardent Health Partners in a research report on Monday, August 12th. They set a "buy" rating and a $21.00 price target on the stock. Bank of America downgraded shares of Ardent Health Partners from a "buy" rating to a "neutral" rating and cut their target price for the stock from $22.00 to $19.00 in a research report on Wednesday, November 6th. Morgan Stanley began coverage on Ardent Health Partners in a research note on Monday, August 12th. They issued an "overweight" rating and a $27.00 price target on the stock. Finally, Royal Bank of Canada assumed coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They set an "outperform" rating and a $23.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Ardent Health Partners has a consensus rating of "Buy" and an average price target of $21.82.

Ardent Health Partners Stock Down 0.8 %

Ardent Health Partners stock traded down $0.14 during mid-day trading on Tuesday, reaching $17.17. 170,150 shares of the company were exchanged, compared to its average volume of 378,149. The company has a quick ratio of 1.54, a current ratio of 1.65 and a debt-to-equity ratio of 0.93. Ardent Health Partners has a 12-month low of $14.57 and a 12-month high of $20.72. The firm's fifty day moving average is $18.42.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last issued its quarterly earnings results on Wednesday, August 14th. The company reported $0.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.30 by $0.05. The business had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.46 billion. On average, analysts forecast that Ardent Health Partners will post 1.28 earnings per share for the current fiscal year.

Institutional Trading of Ardent Health Partners

Several institutional investors and hedge funds have recently bought and sold shares of the business. Charles Schwab Investment Management Inc. purchased a new position in Ardent Health Partners in the 3rd quarter valued at approximately $526,000. Financial Management Professionals Inc. purchased a new position in Ardent Health Partners in the 3rd quarter valued at about $50,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of Ardent Health Partners during the 3rd quarter valued at approximately $13,119,000. Finally, Seven Grand Managers LLC acquired a new stake in shares of Ardent Health Partners in the third quarter valued at approximately $2,298,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.